AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ventana Biotech, Inc.

$0.05 +$0.01 (+32.79%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.05
Day Range
$0.03$0.05
Year Range
$0.02$0.08
Market Cap
134.91K
AVG Volume
311
Trailing/Forward PE
30.62/-
PEG ratio
0.1
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
050K100K150K23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
VNTA Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
25 Q3114.58K
25 Q267.66K
25 Q121.4K
24 Q441.11K
24 Q341.36K
24 Q258.03K
24 Q139.65K
23 Q429.09K
23 Q330.47K
Net Income (USD) · TTM
025K50K75K100K23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
VNTA Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
25 Q386.14K
25 Q249.77K
25 Q13.37K
24 Q420.34K
24 Q319.89K
24 Q239.93K
24 Q126.2K
23 Q416.6K
23 Q317.28K
Operating Income (USD) · TTM
050K100K150K23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
VNTA Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
25 Q3100.81K
25 Q250.64K
25 Q14.25K
24 Q421.24K
24 Q320.8K
24 Q240.73K
24 Q127K
23 Q417.37K
23 Q318.46K
EBITDA (USD) · TTM
050K100K150K23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
VNTA EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
25 Q3100.81K
25 Q250.64K
25 Q14.25K
24 Q421.24K
24 Q320.8K
24 Q240.73K
24 Q127K
23 Q417.37K
23 Q318.46K
EPS (USD) · TTM
0000023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
VNTA EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
25 Q30
25 Q20
25 Q10
24 Q40
24 Q30
24 Q20
24 Q10
23 Q40
23 Q30
Expenses (USD) · TTM
010K20K30K23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
VNTA Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
25 Q313.76K
25 Q217.01K
25 Q117.15K
24 Q419.87K
24 Q320.57K
24 Q217.3K
24 Q115.4K
23 Q413.1K
23 Q313.38K
PE Ratio
050010001500med 39.98Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
VNTA PE Ratio by quarter
PeriodPE Ratio
Sep 2630.59
Sep 2630.59
Aug 2630.59
Aug 2630.59
Aug 2630.59
Aug 2620.6
Jul 2620.6
Jul 2620.6
Jul 2620.6
Jul 2620.6
Jul 2639.34
Jun 2639.34
Jun 2639.34
Jun 2636.84
Jun 2623.1
May 2623.1
May 2623.1
May 2623.1
May 2623.1
May 2625.6
Apr 2625.6
Apr 2625.6
Apr 2625.6
Apr 2625.04
Mar 2639.98
Mar 2639.98
Mar 2639.98
Mar 2639.98
Feb 2639.98
Feb 2639.98
Feb 2639.98
Feb 2639.98
Jan 2639.98
Jan 2640.52
Jan 2639.98
Jan 2639.87
Jan 2639.87
Dec 25637.62
Dec 25972.54
Dec 25972.54
Dec 25972.54
Nov 251034.54
Nov 25731.51
Nov 25766.74
Nov 25766.74
Oct 25768.34
Oct 25768.34
Oct 251259.31
Oct 25513.29
Oct 25345.91
Sep 2557.39
Sep 2558.18
Sep 2557.39
Sep 2557.39
Aug 2557.39
Aug 2557.39
Aug 2557.39
Aug 2557.39
Aug 2556.86
Jul 2556.86
Jul 2556.86
Jul 2563.73
Jul 2563.73
Jun 2565.17
Jun 2565.17
Jun 2565.17
Jun 2565.11
May 2565.11
May 2565.11
May 2581.36
May 2548.94
May 2548.94
Apr 2547.32
Apr 2567.57
Apr 2567.57
Apr 2529.74
Mar 25158.27
Mar 2512.39
Mar 2512.39
Mar 2512.39
Feb 2510.91
Feb 2510.78
Feb 2510.78
Feb 259.56
Jan 258.22
Jan 250.67
Jan 250.67
Jan 2510.78
Jan 2510.78
Dec 2416.42
Dec 2459.12
Dec 2459.12
Dec 24123.16
Nov 2416.42
Nov 24328.44
Nov 24328.44
Nov 24328.44
Nov 24862.14
Oct 24862.14
Oct 24862.14
Price to Sales
0200400600med 29.06Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
VNTA Price to Sales by quarter
PeriodPrice to Sales
Sep 2623
Sep 2623
Aug 2623
Aug 2623
Aug 2623
Aug 2615.49
Jul 2615.49
Jul 2615.49
Jul 2615.49
Jul 2615.49
Jul 2629.57
Jun 2629.57
Jun 2629.57
Jun 2627.7
Jun 2617.37
May 2617.37
May 2617.37
May 2617.37
May 2617.37
May 2619.25
Apr 2619.25
Apr 2619.25
Apr 2619.25
Apr 2618.82
Mar 2629.41
Mar 2629.41
Mar 2629.41
Mar 2629.41
Feb 2629.41
Feb 2629.41
Feb 2629.41
Feb 2629.41
Jan 2629.41
Jan 2629.81
Jan 2629.41
Jan 2629.33
Jan 2629.33
Dec 25100.53
Dec 25153.33
Dec 25153.33
Dec 25153.33
Nov 25163.11
Nov 25115.33
Nov 25120.89
Nov 25120.89
Oct 25121.14
Oct 25121.14
Oct 25198.55
Oct 2580.93
Oct 2554.54
Sep 2528.39
Sep 2528.78
Sep 2528.39
Sep 2528.39
Aug 2528.39
Aug 2528.39
Aug 2528.39
Aug 2528.39
Aug 2528.13
Jul 2528.13
Jul 2528.13
Jul 2531.53
Jul 2531.53
Jun 2531.34
Jun 2531.34
Jun 2531.34
Jun 2531.31
May 2531.31
May 2531.31
May 2539.13
May 2523.54
May 2523.54
Apr 2522.76
Apr 2532.49
Apr 2532.49
Apr 2514.3
Mar 25108.9
Mar 258.53
Mar 258.53
Mar 258.53
Feb 257.51
Feb 257.41
Feb 257.41
Feb 256.58
Jan 255.65
Jan 250.46
Jan 250.46
Jan 257.41
Jan 257.41
Dec 2410.85
Dec 2439.06
Dec 2439.06
Dec 2481.38
Nov 2410.85
Nov 24217.02
Nov 24217.02
Nov 24217.02
Nov 24569.68
Oct 24569.68
Oct 24569.68
EV/EBITDA
01000200030004000med 227.94Apr 24Jun 24Aug 24Apr 25Jun 25Aug 25Sep 25
VNTA EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2557.39
Sep 2558.15
Sep 2557.39
Sep 2557.39
Aug 2557.39
Aug 2557.39
Aug 2557.39
Aug 2557.39
Aug 2556.88
Jul 2556.88
Jul 2556.88
Jul 2563.46
Jul 2563.46
Jun 2564.62
Jun 2564.62
Jun 2564.62
Jun 2564.57
May 2564.57
May 2564.57
May 2580.11
May 2549.1
May 2549.1
Apr 2547.55
Apr 2566.92
Apr 2566.92
Apr 2530.74
Sep 24375.76
Sep 242605.38
Sep 242605.38
Sep 242964.59
Aug 243224.71
Aug 242853.11
Aug 243038.91
Aug 243038.91
Aug 242853.11
Jul 242853.11
Jul 242853.11
Jul 242853.11
Jul 243100.85
Jun 242916.57
Jun 242916.57
Jun 243732.13
Jun 243732.13
May 243732.13
May 242683.55
May 242683.55
May 242683.55
May 243499.11
Apr 243499.11
Apr 243499.11
Apr 243033.08
Apr 243033.08
Ventana Biotech, Inc.
VNTA
Stockpicker

Video analysis: VNTA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: VNTA

Vanta Announces Engagement of Independent Trading Group for Market-Making Services to Support Strategic Capital Markets Initiatives

accessnewswire.com · 27 Aug 2026

Vanta Announces Engagement of Independent Trading Group for Market-Making Services to Support Strategic Capital Markets Initiatives

VANCOUVER, BC / ACCESS Newswire / August 27, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences and longevity company focused on preventative wellness and healthspan extension, and parent of the Vanta premium longevity brand, announces that it has engaged the services of Independent Trading Group (ITG) Inc. ("ITG") to provide market-making services in accordance with Canadian Securities Exchange ("CSE") policies, effective August 27, 2026. The engagement of ITG forms part of the Company's broader strategic capital markets initiatives, aimed at enhancing trading liquidity, supporting orderly market conditions, and improving overall market quality for the Company's common shares.

Vanta Announces Updated Time for Participation in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 12:00 p.m. ET

accessnewswire.com · 21 Jul 2026

Vanta Announces Updated Time for Participation in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 12:00 p.m. ET

VANCOUVER, BC / ACCESS Newswire / July 21, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences and longevity company focused on preventative wellness and healthspan extension, and parent of the Vanta premium longevity brand, announces that, further to its news release dated July 6, 2026, regarding the Company's participation in Maxim Group LLC's ("Maxim Group") "Health, Wellness & Longevity" virtual conference, the scheduled time of the fireside chat featuring Marcello Leone, Chief Executive Officer of Vanta, has been updated. The fireside chat will now take place on Wednesday, July 22, 2026, at 12:00 p.m.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.